IFRX
Price
$0.79
Change
-$0.02 (-2.47%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
54.73M
31 days until earnings call
VERA
Price
$23.57
Change
+$0.92 (+4.06%)
Updated
Jun 30, 04:59 PM (EDT)
Capitalization
1.44B
38 days until earnings call
Interact to see
Advertisement

IFRX vs VERA

Header iconIFRX vs VERA Comparison
Open Charts IFRX vs VERABanner chart's image
InflaRx
Price$0.79
Change-$0.02 (-2.47%)
Volume$779
Capitalization54.73M
Vera Therapeutics
Price$23.57
Change+$0.92 (+4.06%)
Volume$37.86K
Capitalization1.44B
IFRX vs VERA Comparison Chart in %
Loading...
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IFRX vs. VERA commentary
Jul 01, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IFRX is a Hold and VERA is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 01, 2025
Stock price -- (IFRX: $0.81 vs. VERA: $22.65)
Brand notoriety: IFRX and VERA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IFRX: 28% vs. VERA: 132%
Market capitalization -- IFRX: $54.73M vs. VERA: $1.44B
IFRX [@Biotechnology] is valued at $54.73M. VERA’s [@Biotechnology] market capitalization is $1.44B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IFRX’s FA Score shows that 0 FA rating(s) are green whileVERA’s FA Score has 0 green FA rating(s).

  • IFRX’s FA Score: 0 green, 5 red.
  • VERA’s FA Score: 0 green, 5 red.
According to our system of comparison, VERA is a better buy in the long-term than IFRX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IFRX’s TA Score shows that 5 TA indicator(s) are bullish while VERA’s TA Score has 2 bullish TA indicator(s).

  • IFRX’s TA Score: 5 bullish, 4 bearish.
  • VERA’s TA Score: 2 bullish, 7 bearish.
According to our system of comparison, IFRX is a better buy in the short-term than VERA.

Price Growth

IFRX (@Biotechnology) experienced а +1.58% price change this week, while VERA (@Biotechnology) price change was +8.69% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.69%. For the same industry, the average monthly price growth was +32.93%, and the average quarterly price growth was +6.81%.

Reported Earning Dates

IFRX is expected to report earnings on Jul 31, 2025.

VERA is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Biotechnology (+3.69% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
VERA($1.44B) has a higher market cap than IFRX($54.7M). VERA YTD gains are higher at: -46.441 vs. IFRX (-67.296). IFRX has higher annual earnings (EBITDA): -44.22M vs. VERA (-167.77M). VERA has more cash in the bank: 590M vs. IFRX (65.9M). IFRX has less debt than VERA: IFRX (703K) vs VERA (54.5M). IFRX has higher revenues than VERA: IFRX (130K) vs VERA (0).
IFRXVERAIFRX / VERA
Capitalization54.7M1.44B4%
EBITDA-44.22M-167.77M26%
Gain YTD-67.296-46.441145%
P/E RatioN/AN/A-
Revenue130K0-
Total Cash65.9M590M11%
Total Debt703K54.5M1%
FUNDAMENTALS RATINGS
IFRX: Fundamental Ratings
IFRX
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
63
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
97
PRICE GROWTH RATING
1..100
65
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IFRXVERA
RSI
ODDS (%)
Bullish Trend 4 days ago
90%
Bearish Trend 4 days ago
78%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
87%
Bearish Trend 4 days ago
84%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
87%
MACD
ODDS (%)
Bullish Trend 4 days ago
85%
Bearish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 4 days ago
88%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
89%
Bullish Trend 4 days ago
90%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
86%
Declines
ODDS (%)
Bearish Trend 4 days ago
88%
Bearish Trend 4 days ago
83%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
88%
Bearish Trend 4 days ago
72%
Aroon
ODDS (%)
Bullish Trend 5 days ago
84%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
IFRX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
VERA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RDEIY10.790.11
+1.03%
Redeia Corporacion SA
HINOF2.54N/A
N/A
Hino Motors Ltd.
JWCTF0.25N/A
N/A
JW CAYMAN THERAPEUTICS CO LTD.
CNLTN32.50N/A
N/A
Connecticut Light & Power Co. (The)
CRZY30.12N/A
N/A
Crazy Woman Creek Bancorp Inc.

IFRX and

Correlation & Price change

A.I.dvisor tells us that IFRX and LXEO have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that IFRX and LXEO's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IFRX
1D Price
Change %
IFRX100%
-2.98%
LXEO - IFRX
29%
Poorly correlated
-1.44%
RCUS - IFRX
28%
Poorly correlated
-6.47%
VERA - IFRX
28%
Poorly correlated
-2.75%
NMRA - IFRX
26%
Poorly correlated
-5.32%
ARWR - IFRX
26%
Poorly correlated
+0.06%
More

VERA and

Correlation & Price change

A.I.dvisor indicates that over the last year, VERA has been loosely correlated with KYMR. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if VERA jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To VERA
1D Price
Change %
VERA100%
-2.75%
KYMR - VERA
54%
Loosely correlated
-3.48%
LYRA - VERA
53%
Loosely correlated
-31.91%
OPORF - VERA
50%
Loosely correlated
N/A
BPMC - VERA
47%
Loosely correlated
-0.03%
BNTX - VERA
40%
Loosely correlated
+0.55%
More